March 3, 2026

Integra LifeSciences Holdings C (IART) Stock Analysis: Evaluating a 45% Upside Potential Amidst Market Challenges

Integra LifeSciences Holdings Corporation (NASDAQ: IART) remains a notable player in the healthcare sector, specifically within the medical devices industry. Headquartered in Princeton, New Jersey, Integra..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: A Potential 36% Upside for Investors in Pain Management Solutions

Investors focusing on the healthcare sector may find Pacira BioSciences, Inc. (NASDAQ: PCRX) a compelling option, particularly given the company’s strong foothold in non-opioid pain management..

Disc Medicine, Inc. (IRON) Stock Analysis: A 50% Potential Upside in the Biotech Sector

Disc Medicine, Inc. (NASDAQ: IRON) stands out in the healthcare sector with a promising outlook in the biotechnology industry. Despite its current trading price of $66.54,..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: 136% Potential Upside Captivates Investor Interest

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a prominent player in the biotechnology sector, is capturing the attention of investors with its promising portfolio and remarkable potential upside...

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Exploring a 19% Upside Potential

Investors looking for growth opportunities in the healthcare sector may find Amneal Pharmaceuticals, Inc. (NYSE: AMRX) an intriguing candidate. This global biopharmaceutical company, with a market..

Zai Lab Limited (ZLAB) Stock Analysis: Exploring a 113.65% Upside Potential

Zai Lab Limited (NASDAQ: ZLAB), a leading biopharmaceutical company based in China, stands at a pivotal moment in its journey. With an impressive market cap of..

PROCEPT BioRobotics Corporation (PRCT) Investor Outlook: Unveiling the 23.55% Potential Upside in Healthcare Robotics

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) is steadily carving its niche in the healthcare sector, specifically within the medical devices industry. Headquartered in San Jose, California, the..

Aurinia Pharmaceuticals Inc (AUPH): Investor Outlook Reveals 19.63% Potential Upside

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH), a key player in the biotechnology sector, is capturing investor interest with its promising potential upside of 19.63%. Headquartered in Edmonton,..

Guardian Pharmacy Services, Inc (GRDN): A Strong Buy with Promising Growth Potential in the Healthcare Sector

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN), a key player in the healthcare sector, operates within the medical care facilities industry, focusing on long-term health care facilities..

Kestra Medical Technologies (KMTS) Stock Analysis: Exploring 27% Potential Upside in Healthcare Innovation

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) is making waves in the healthcare sector, particularly within the medical instruments and supplies industry. Founded in 2014 and headquartered..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: A 26.86% Potential Upside in the Healthcare Sector

U.S. Physical Therapy, Inc. (NYSE: USPH) has been garnering attention among investors, particularly those with an interest in the healthcare sector. With a market capitalization of..

AdaptHealth Corp. (AHCO) Stock Analysis: Exploring a 33.56% Potential Upside in the Medical Devices Sector

AdaptHealth Corp. (NASDAQ: AHCO) stands as a significant player in the U.S. healthcare landscape, operating within the medical devices industry. Despite facing certain operational challenges, the..

Novavax, Inc. (NVAX) Stock Analysis: Evaluating a 36% Potential Upside in a Volatile Biotech Sector

Novavax, Inc. (NASDAQ: NVAX), a prominent player in the biotechnology sector, presents an intriguing opportunity for investors as it navigates the complexities of vaccine development and..

Neogen Corporation (NEOG) Stock Analysis: Navigating Growth Prospects Amid Market Challenges

Neogen Corporation (NASDAQ: NEOG), a prominent player in the healthcare sector specializing in medical devices, has captured investor attention with its diverse portfolio focused on food..

Privia Health Group, Inc. (PRVA) Stock Analysis: A 31.8% Upside Lures Investors in the Booming Healthcare Sector

Privia Health Group, Inc. (NASDAQ: PRVA), a prominent player in the healthcare sector, is capturing the attention of investors with its innovative approach to physician enablement..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: Exploring the 33% Potential Upside

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) is a dynamic player in the biotechnology sector, headquartered in Cambridge, Massachusetts. The company is renowned for its innovative approach to..

Viridian Therapeutics, Inc. (VRDN): Investor Outlook on a Biotech Powerhouse with 38% Upside Potential

Viridian Therapeutics, Inc. (NASDAQ: VRDN) has emerged as a compelling player in the biotechnology sector with its innovative approach to addressing serious and rare diseases. With..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Strong Buy Ratings Signal Potential 73% Upside

Structure Therapeutics Inc. (NASDAQ: GPCR) is capturing investor interest with its significant growth potential in the biotechnology sector. The company, with its $4.44 billion market cap,..

Evotec SE (EVO) Stock Analysis: Exploring a Potential 67.92% Upside Amidst Financial Challenges

Evotec SE (EVO) presents a compelling case for investors willing to navigate the complexities of the healthcare sector, specifically within drug manufacturing. Headquartered in Hamburg, Germany,..

Dynavax Technologies Corporation (DVAX): Investor Outlook with a Focus on Revenue Growth and Market Position

Dynavax Technologies Corporation (NASDAQ: DVAX) is making waves in the healthcare sector with a robust focus on vaccine development and commercialization. As a commercial-stage biopharmaceutical company,..

Search

Funds

March 3, 2026

Search

Funds

March 3, 2026

FTSE 100

Funds